<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cavka L</submitter><funding>Slovenian Research Agency</funding><funding>lovenian Research Agency (ARRS)</funding><pagination>1044</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9964768</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(4)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Prognostic role of nutritional status (NS) in patients with metastatic castrate-resistant prostate cancer (mCRPC) is unknown. We hypothesized that patients' NS at the presentation of mCRPC is prognostic for health-related quality of life (HRQoL) and overall survival (OS).&lt;h4>Methods&lt;/h4>We conducted a prospective observational study in mCRPC patients. At enrollment, we allocated each patient into one of four NS categories: (i) well-nourished (WN), (ii) nutritional risk without sarcopenia/cachexia (NR), (iii) sarcopenia, or (iv) cachexia. We sought the prognostic role of the NS for OS and HRQoL by regression models.&lt;h4>Results&lt;/h4>141 patients were included into our study. When compared to WN patients, those with NR and cachexia had a higher chance of worse HRQoL (OR 3.45; 9</pubmed_abstract><journal>Nutrients</journal><pubmed_title>Prognostic Impact of Nutritional Status on Overall Survival and Health-Related Quality of Life in Men with Advanced Prostate Cancer.</pubmed_title><pmcid>PMC9964768</pmcid><funding_grant_id>P3-0321</funding_grant_id><pubmed_authors>Rotovnik Kozjek N</pubmed_authors><pubmed_authors>Seruga B</pubmed_authors><pubmed_authors>Cavka L</pubmed_authors><pubmed_authors>Pohar Perme M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic Impact of Nutritional Status on Overall Survival and Health-Related Quality of Life in Men with Advanced Prostate Cancer.</name><description>&lt;h4>Purpose&lt;/h4>Prognostic role of nutritional status (NS) in patients with metastatic castrate-resistant prostate cancer (mCRPC) is unknown. We hypothesized that patients' NS at the presentation of mCRPC is prognostic for health-related quality of life (HRQoL) and overall survival (OS).&lt;h4>Methods&lt;/h4>We conducted a prospective observational study in mCRPC patients. At enrollment, we allocated each patient into one of four NS categories: (i) well-nourished (WN), (ii) nutritional risk without sarcopenia/cachexia (NR), (iii) sarcopenia, or (iv) cachexia. We sought the prognostic role of the NS for OS and HRQoL by regression models.&lt;h4>Results&lt;/h4>141 patients were included into our study. When compared to WN patients, those with NR and cachexia had a higher chance of worse HRQoL (OR 3.45; 9</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-08-24T03:08:26.1Z</modification><creation>2025-04-04T08:53:13.15Z</creation></dates><accession>S-EPMC9964768</accession><cross_references><pubmed>36839402</pubmed><doi>10.3390/nu15041044</doi></cross_references></HashMap>